Joint development and sales of a darbepoetin alfa biosimilar
An individual product theme involving the joint development in Japan with 三和化学研究所 of a darbepoetin alfa biosimilar, taking it from clinical trials through commercial launch and generating sales-linked royalty income.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.